Prevalence of adherence to cardiovascular drugs in outpatients with coronary artery disease
DOI:
https://doi.org/10.30968/rbfhss.2020.112.0459Abstract
Objectives: To describe the prevalence of adherence to drug treatment and the association with sociodemographic, clinical and pharmacotherapeutic factors, in patients diagnosed with coronary artery disease, seen at a multiprofessional cardiology clinic in a public hospital in Belo Horizonte, Minas Gerais. Methods: This is a cross-sectional study conducted between April 2018 and February 2019 in a multiprofessional outpatient cardiology clinic at a teaching hospital. The dependent variable is adherence to treatment with cardiovascular drugs measured by self-report using the 7-day recall and the independent variables evaluated were the sociodemographic, clinical and pharmacotherapeutic variables. Descriptive analysis was performed using frequency distributions for categorical variables and measures of central tendency and dispersion for continuous variables. The association between treatment adherence and independent variables was performed using bivariate analysis using Pearson's chi-square test and the magnitude of the association was expressed by the odds ratio with a 95% confidence interval. Results: 148 patients with a median age of 62 years (IQR = 17.0), mostly male (104; 70.3%) and a median of four years of education (IQR = 4.0). The most prevalent cardiovascular diagnosis was ST-segment elevation acute myocardial infarction (58.8%), followed by non-ST-segment elevation acute myocardial infarction (26.4%) and arrhythmia (23.7%). The most frequent comorbidities were hypertension (72.3%) and diabetes (33.1%). Beta-blockers 98.1% (n = 130) and renin-angiotensin system agents 68.3% (n = 101) were the most commonly used cardiovascular drug classes. No statistically significant association was identified between adherence and sociodemographic, clinical and pharmacotherapeutic factors. Conclusion: The frequency of adherence to treatment measured by 7-days recall was high.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Authors
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The authors hereby transfer, assign, or otherwise convey to RBFHSS: (1) the right to grant permission to republish or reprint the stated material, in whole or in part, without a fee; (2) the right to print republish copies for free distribution or sale; and (3) the right to republish the stated material in any format (electronic or printed). In addition, the undersigned affirms that the article described above has not previously been published, in whole or part, is not subject to copyright or other rights except by the author(s), and has not been submitted for publication elsewhere, except as communicated in writing to RHFHSS with this document.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC-BY-NC-ND) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Serlf-archiving policy
This journal permits and encourages authors to post and archive the final pdf of the articles submitted to the journal on personal websites or institutional repositories after publication, while providing bibliographic details that credit its publication in this journal.